RBBN(RBBN)
RBBN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $838M | $866M |
| Low | $835M | $861M |
| High | $841M | $871M |
| EBITDA Avg | $239M | $247M |
| Low | $238M | $246M |
| High | $240M | $248M |
| EBIT Avg | $200M | $207M |
| Low | $199M | $205M |
| High | $201M | $208M |
| Net Income Avg | $8M | $28M |
| Low | $8M | $26M |
| High | $9M | $28M |
| EPS Avg | $0.05 | $0.16 |
| Low | $0.04 | $0.15 |
| High | $0.05 | $0.16 |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $222M | $247M | $194M | $211M | $222M | $241M |
| Low | $221M | $245M | $193M | $209M | $220M | $239M |
| High | $223M | $248M | $196M | $213M | $224M | $243M |
| EBITDA Avg | $63M | $70M | $55M | $60M | $63M | $69M |
| Low | $63M | $70M | $55M | $60M | $63M | $68M |
| High | $64M | $71M | $56M | $61M | $64M | $69M |
| EBIT Avg | $53M | $59M | $46M | $50M | $53M | $57M |
| Low | $53M | $58M | $46M | $50M | $53M | $57M |
| High | $53M | $59M | $47M | $51M | $53M | $58M |
| Net Income Avg | $7M | $16M | $-3M | $4M | $10M | $17M |
| Low | $7M | $14M | $-3M | $4M | $10M | $17M |
| High | $7M | $16M | $-3M | $4M | $10M | $17M |
| EPS Avg | $0.04 | $0.09 | $-0.01 | $0.03 | $0.06 | $0.10 |
| Low | $0.04 | $0.08 | $-0.02 | $0.02 | $0.05 | $0.09 |
| High | $0.04 | $0.09 | $-0.01 | $0.03 | $0.06 | $0.10 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |